These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 5959285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hormone therapy of threatened abortion].
    Stojanov S.
    Zentralbl Gynakol; 1972 Oct 07; 94(40):1323-6. PubMed ID: 4118064
    [No Abstract] [Full Text] [Related]

  • 4. [Sequential therapeutics in gynecology. (Apropos of 40 cases)].
    Gelle P, Vitse M, Duthoit F, Silberberg L, Lescut JC.
    Lille Med; 1968 Apr 07; 13(4):Suppl:511-4. PubMed ID: 4176311
    [No Abstract] [Full Text] [Related]

  • 5. [The practical physician and his attitude towards the problem of hormone therapy in gynecology].
    Jäger G.
    Z Arztl Fortbild (Jena); 1967 Dec 01; 61(23):1193-8. PubMed ID: 5627209
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hormonal studies and clinical observations in patients with threatening abortion or premature birth, respectively treated with depot-17-alpha-hydroxyprogesterone-caproate].
    Tóth F, Kónya Z.
    Z Geburtshilfe Gynakol; 1971 Oct 01; 175(2):168-75. PubMed ID: 5118523
    [No Abstract] [Full Text] [Related]

  • 8. Importance of hormone assays and high dose HCG, estrogen and 17-alpha-hydroxyprogesterone treatment in the prevention of threatened abortion due to endocrine causes.
    Cubesi G, Plancher G, Destro F.
    Acta Eur Fertil; 1970 Sep 01; 2(3):355-8. PubMed ID: 5538329
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Gynecological indications of a new progestational agent with prolonged action].
    Goisis M, Candotti G.
    Minerva Ginecol; 1970 Mar 31; 22(6):339-67. PubMed ID: 5515153
    [No Abstract] [Full Text] [Related]

  • 15. [Indications and methods for hormonal cyclic regulation].
    Leinzinger E.
    Wien Med Wochenschr; 1966 Jun 18; 116(25):581-3. PubMed ID: 5995252
    [No Abstract] [Full Text] [Related]

  • 16. [Gestagens].
    Pigeaud H.
    Maroc Med; 1967 Apr 18; 47(501):291-5. PubMed ID: 5629914
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The study of the effectiveness of 17-alpha-hydroxyprogesterone capronate in the treatment of threatened abortion].
    Kubinyi J, Pilishegyi J.
    Orv Hetil; 1969 Mar 23; 110(12):654-5. PubMed ID: 4889626
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.